Why is Jiangsu Canopus Wisdom Medical Technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 7.28%
- The company has been able to generate a Return on Capital Employed (avg) of 7.28% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -2.69% and Operating profit at -19.50% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 4.24% signifying low profitability per unit of shareholders funds
3
The company has declared Negative results for the last 5 consecutive quarters
- NET PROFIT(9M) At CNY 36.54 MM has Grown at -42.78%
- INTEREST(HY) At CNY 0.82 MM has Grown at 158.83%
- OPERATING CASH FLOW(Y) Lowest at CNY 117.71 MM
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 14.25%, its profits have fallen by -44%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jiangsu Canopus Wisdom Medical Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jiangsu Canopus Wisdom Medical Technology Co., Ltd.
14.25%
1.09
35.44%
China Shanghai Composite
19.22%
1.40
13.75%
Quality key factors
Factor
Value
Sales Growth (5y)
-2.69%
EBIT Growth (5y)
-19.50%
EBIT to Interest (avg)
78.20
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.18
Tax Ratio
15.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.28%
ROE (avg)
4.24%
Valuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.34
EV to EBIT
-7.53
EV to EBITDA
-4.64
EV to Capital Employed
-0.36
EV to Sales
-0.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
2.34%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
6What is working for the Company
NET PROFIT(HY)
Higher at CNY 118.18 MM
RAW MATERIAL COST(Y)
Fallen by -33.34% (YoY
-18What is not working for the Company
NET PROFIT(9M)
At CNY 36.54 MM has Grown at -42.78%
INTEREST(HY)
At CNY 0.82 MM has Grown at 158.83%
OPERATING CASH FLOW(Y)
Lowest at CNY 117.71 MM
ROCE(HY)
Lowest at -1.45%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.83 times
Here's what is working for Jiangsu Canopus Wisdom Medical Technology Co., Ltd.
Net Profit
At CNY 118.18 MM has Grown at 171.32%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Profit
Higher at CNY 118.18 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -33.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jiangsu Canopus Wisdom Medical Technology Co., Ltd.
Interest
At CNY 0.82 MM has Grown at 158.83%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Cash Flow
Lowest at CNY 117.71 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Lowest at 1.83 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






